Dr. Reddy's Laboratories (DRREDDY) Share Price & Analysis
Dr. Reddy's Laboratories (DRREDDY) — Drug Manufacturers - Specialty & Generic
Dr. Reddy's Laboratories Key Fundamental Metrics
Executive Investment Overview & Business Profile
Dr. Reddy's Laboratories trades at a balanced P/E of 29.45912, reflecting strong institutional market trust and consistent compound returns.
Dr. Reddy's Laboratories is one of the premier companies in India's Healthcare sector. Currently trading at ₹1,171 with a market capitalization of ₹97544.31 Cr, the company occupies a key position in the Indian equity market.
Investors evaluating Dr. Reddy's Laboratories focus closely on its capital return metrics: Return on Equity (ROE) stands at 8.84% alongside operating margins of 4.25%. The company's earnings multiple of 29.45912 P/E provides a clear signal of market expectation relative to sector peers.
Company Profile & Information
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.